GF
AUPH icon

Gabelli Funds’s Aurinia Pharmaceuticals AUPH Stock Holding History

Gabelli Funds’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-280,000
Closed -$2.11M – 1217
2022
Q3 		$2.11M Sell
280,000
-110,000
-28% -$952K 0.02% 640
2022
Q2 		$3.92M Hold
390,000
– – 0.03% 515
2022
Q1 		$4.83M Buy
390,000
+30,000
+8% +$464K 0.03% 515
2021
Q4 		$8.23M Buy
360,000
+45,000
+14% +$1.07M 0.05% 385
2021
Q3 		$6.97M Buy
315,000
+25,000
+9% +$397K 0.05% 425
2021
Q2 		$3.76M Buy
290,000
+55,000
+23% +$701K 0.02% 598
2021
Q1 		$3.05M Buy
+235,000
New +$3.41M 0.02% 634

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return